NDC 0069-0235 – Cibinqo
Abrocitinib 50 mg/1 · Tablet, Film Coated · Oral
Product NDC0069-0235
Product details
- Brand name
- Cibinqo
- Generic name
- abrocitinib
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA213871
- Marketed since
- February 24, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Janus Kinase Inhibitor
Active ingredients
- Abrocitinib 50 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0069-0235-30 | 30 TABLET, FILM COATED in 1 BOTTLE (0069-0235-30) | Feb 24, 2022 |
Other Cibinqo products
- 0069-0335 Abrocitinib 100 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 0069-0435 Abrocitinib 200 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 63539-236 Abrocitinib 50 mg/1 · Tablet, Film Coated · U.S. Pharmaceuticals
- 63539-336 Abrocitinib 100 mg/1 · Tablet, Film Coated · U.S. Pharmaceuticals
- 63539-436 Abrocitinib 200 mg/1 · Tablet, Film Coated · U.S. Pharmaceuticals